Best Exercise for Depression? Walking, Jogging, and Dose

The first useful exercise prescription for depression

"Exercise helps depression" has been true for years and useless for almost as long. Helpful for whom? What kind? How hard? Compared with what?

A large 2024 BMJ network meta-analysis by Noetel et al. finally made the question concrete. It pooled 218 randomized controlled trials with 14,170 participants and compared exercise modalities against one another and against antidepressants and cognitive behavioral therapy within the same evidence network. Walking and jogging came out on top, with a standardized effect size of Hedges' g = -0.62 versus active controls (95% CI, -0.80 to -0.43). In that same network, antidepressants were about g = -0.26 and CBT about g = -0.43.

That does not prove jogging beats medication in every clinic, for every patient, in every severity band. It does mean the strongest synthesis we have puts walking and jogging at the top of the exercise list and above first-line comparators on the same scale. That is a real prescription, not wellness wallpaper.

Best-supported option for working-age adults with major depression: consistent walking or jogging, preferably at vigorous intensity, because that is the modality and dose pattern with the strongest evidence in the largest trial network.

What the main trial network actually found

The strength of the BMJ analysis is not just its size. A network meta-analysis can compare treatments even when individual trials did not test them head to head. That matters here because older evidence often stopped at "exercise versus control," which is fine if your only goal is to confirm that motion beats the couch.

Noetel et al. ranked several modalities against active controls. Walking and jogging led at g = -0.62. Yoga followed at g = -0.55. Resistance training was close at g = -0.54. Mixed aerobic exercise came in at g = -0.43. Dance posted the largest point estimate, g = -0.96, but the confidence intervals were wide and the underlying evidence base was much smaller, so it is a bad candidate for a broad recommendation right now. Sometimes the biggest number in the room is just the least stable one.

The same analysis found that vigorous-intensity exercise produced larger antidepressant effects than moderate or light exercise. That matters because the argument is not simply "move more." Intensity changed the outcome.

The authors rated confidence in the walking-and-jogging finding as moderate, not high, mainly because exercise trials cannot blind participants or staff. People know whether they are jogging. That is a structural limitation of behavioral research, not a sign that the effect vanished under scrutiny.

Why intensity probably matters

The dose story does not rest on one paper. An adolescent-focused 2025 network meta-analysis by Ma et al., covering 58 randomized trials, also found a dose-response gradient for depression outcomes. A 2025 systematic review by Zeng et al. adds support at the high-intensity end, though it also highlights a practical problem: trials do not define "high" and "vigorous" in exactly the same way, and adherence at the hardest intensities is not always reported well.

That leaves a sensible conclusion and an unanswered question. The conclusion is that moderate exercise helps and vigorous exercise tends to help more. The unanswered question is where the ceiling sits. The available evidence does not tell us the exact point where pushing intensity higher stops helping or starts backfiring.

Older adults add another layer. A 2024 network meta-analysis by Tang et al. found that adults over roughly 60 needed at least 400 MET-minutes per week before exercise reliably beat control for depressive symptoms. Below that threshold, the result was not statistically superior to control. That is one of the clearest dose floors in the current literature, but it comes from older adults, so it should not be recycled into a fake universal rule for everyone else.

Why aerobic exercise may have an edge

The mechanistic case is plausible and increasingly coherent, but it is still a mechanistic case. A 2026 review by Montgomery et al. argues that exercise acts on several pathways involved in major depressive disorder: brain-derived neurotrophic factor, or BDNF; monoamines including serotonin, dopamine, and norepinephrine; the stress-response system through lower cortisol signaling; and inflammatory pathways.

The most interesting part is BDNF. A 2025 meta-analysis by Zhu Yuping et al. found that, in patients with depression, aerobic exercise increased serum BDNF more than resistance training or mind-body exercise, with the dose-response curve peaking at moderate-to-vigorous aerobic intensity. That lines up neatly with the clinical ranking from the BMJ analysis.

Still, neat alignment is not proof. Serum BDNF is a biomarker, not a direct readout of what is happening inside the hippocampus in living people with DSM-diagnosed depression. The claim that aerobic exercise preferentially drives hippocampal neurogenesis remains biologically plausible and supported by broader mechanistic literature, but current human evidence does not directly measure hippocampal BDNF release while comparing jogging with lifting weights. The mechanism is credible. It is not nailed shut.

Age does not seem to erase the biology. A 2025 meta-analysis by Gholami et al. found that exercise training in older adults increased resting BDNF concentrations overall, with a pooled standardized mean difference of 0.56 (95% CI, 0.28 to 0.85). Moderate-to-vigorous programs performed especially well. That does not tell us which depressed older adult should do what tomorrow morning, but it supports the broader neuroplasticity story across the adult lifespan.

Where the headline breaks down

The cleanest challenge to "walking and jogging win" comes from older adults. In the Tang et al. analysis, mind-body exercise could match or outperform walking and jogging for depressive symptoms in that age group. That is not a contradiction so much as a reminder that physiology changes with age. A slow walk can be a serious aerobic load for one person and a casual errand for another. Tai chi or yoga may also deliver stress-regulation benefits that matter more in older populations.

Other populations look broadly consistent with the main picture, though the details differ. A 2025 network meta-analysis by Wang et al. supports antidepressant effects of physical activity in menopausal women, a group where stress-axis dysregulation is especially relevant. A 2025 cross-sectional study by Barbosa et al. found that replacing sedentary time with moderate or vigorous physical activity was associated with lower anxiety and depression symptoms in college students. Useful, yes, but it is association, not randomized evidence, and the effect of swapping sitting time is not the same question as the effect of a structured treatment program.

The limits of the evidence

The biggest limitation is simple: exercise trials cannot be truly blinded. Expectancy effects, therapist attention, social contact, and the fact that participants know they are doing something healthy all contaminate the clean ideal of an inert comparator.

Comparator choice is the next problem. In the Noetel et al. network, active controls included usual care, placebo tablets, stretching, education, and social support. That heterogeneity cuts both ways. It makes the analysis more clinically broad, but it also means the effect sizes reflect comparison with a mixed bag rather than one consistent placebo-like control.

The severity question also stays open. The BMJ analysis did not find a statistically significant interaction between baseline depression severity and exercise modality, but the subgroup confidence intervals were wide. Lack of a detected interaction is not proof that the effect is identical in mild, moderate, and severe major depression.

Finally, the combination question remains unresolved. The current network can compare exercise, antidepressants, and CBT within one framework, but it does not settle whether exercise works best alone, with medication, with psychotherapy, or with both. Clinicians still have to practice medicine rather than astrology.

What readers should do with this

If you want the most evidence-based exercise choice for depression in a general adult population, pick walking or jogging and do it consistently enough to reach at least moderate intensity, with vigorous intensity favored when it is safe and sustainable. Resistance training still looks useful. Yoga does too. But the best current ranking puts walking and jogging first.

If you are older, the answer gets less tidy. The evidence suggests a minimum weekly dose matters, and mind-body exercise deserves a serious look rather than being filed under "nice extra."

The broader point is harder to ignore now. Exercise is not just a supportive lifestyle habit that politely trails behind standard treatment. In the best current randomized evidence network, it performs like a primary intervention for depressive symptoms, with walking and jogging at the top of the list. The science still has blind spots. The ranking, for now, is clear enough to use.